296 related articles for article (PubMed ID: 14656471)
1. Genetic studies of the AMH/MIS signaling pathway for Müllerian duct regression.
Jamin SP; Arango NA; Mishina Y; Hanks MC; Behringer RR
Mol Cell Endocrinol; 2003 Dec; 211(1-2):15-9. PubMed ID: 14656471
[TBL] [Abstract][Full Text] [Related]
2. AMH signaling: from receptor to target gene.
Visser JA
Mol Cell Endocrinol; 2003 Dec; 211(1-2):65-73. PubMed ID: 14656478
[TBL] [Abstract][Full Text] [Related]
3. Components of the anti-Müllerian hormone signaling pathway in gonads.
di Clemente N; Josso N; Gouédard L; Belville C
Mol Cell Endocrinol; 2003 Dec; 211(1-2):9-14. PubMed ID: 14656470
[TBL] [Abstract][Full Text] [Related]
4. Welcome to the family: the anti-müllerian hormone receptor.
Grootegoed JA; Baarends WM; Themmen AP
Mol Cell Endocrinol; 1994 Apr; 100(1-2):29-34. PubMed ID: 8056154
[TBL] [Abstract][Full Text] [Related]
5. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
6. Anti-Müllerian hormone and its receptors.
Josso N; di Clemente N; Gouédard L
Mol Cell Endocrinol; 2001 Jun; 179(1-2):25-32. PubMed ID: 11420127
[TBL] [Abstract][Full Text] [Related]
7. The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling.
Visser JA; Olaso R; Verhoef-Post M; Kramer P; Themmen AP; Ingraham HA
Mol Endocrinol; 2001 Jun; 15(6):936-45. PubMed ID: 11376112
[TBL] [Abstract][Full Text] [Related]
8. The in vivo roles of müllerian-inhibiting substance.
Behringer RR
Curr Top Dev Biol; 1994; 29():171-87. PubMed ID: 7828438
[TBL] [Abstract][Full Text] [Related]
9. Anti-Müllerian hormone receptor defect.
di Clemente N; Belville C
Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):599-610. PubMed ID: 17161334
[TBL] [Abstract][Full Text] [Related]
10. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
Donahoe PK; Clarke T; Teixeira J; Maheswaran S; MacLaughlin DT
Mol Cell Endocrinol; 2003 Dec; 211(1-2):37-42. PubMed ID: 14656474
[TBL] [Abstract][Full Text] [Related]
11. AMH induces mesonephric cell migration in XX gonads.
Ross AJ; Tilman C; Yao H; MacLaughlin D; Capel B
Mol Cell Endocrinol; 2003 Dec; 211(1-2):1-7. PubMed ID: 14656469
[TBL] [Abstract][Full Text] [Related]
12. Requirement of Bmpr1a for Müllerian duct regression during male sexual development.
Jamin SP; Arango NA; Mishina Y; Hanks MC; Behringer RR
Nat Genet; 2002 Nov; 32(3):408-10. PubMed ID: 12368913
[TBL] [Abstract][Full Text] [Related]
13. AMH and AMH receptor defects in persistent Müllerian duct syndrome.
Josso N; Belville C; di Clemente N; Picard JY
Hum Reprod Update; 2005; 11(4):351-6. PubMed ID: 15878900
[TBL] [Abstract][Full Text] [Related]
14. β-Catenin is essential for Müllerian duct regression during male sexual differentiation.
Kobayashi A; Stewart CA; Wang Y; Fujioka K; Thomas NC; Jamin SP; Behringer RR
Development; 2011 May; 138(10):1967-75. PubMed ID: 21490063
[TBL] [Abstract][Full Text] [Related]
15. Testicular anti-Müllerian hormone: history, genetics, regulation and clinical applications.
Josso N; Picard JY; Rey R; di Clemente N
Pediatr Endocrinol Rev; 2006 Jun; 3(4):347-58. PubMed ID: 16816803
[TBL] [Abstract][Full Text] [Related]
16. Genetic studies of MIS signalling in sexual development.
Jamin SP; Arango NA; Mishina Y; Behringer RR
Novartis Found Symp; 2002; 244():157-64; discussion 164-8, 203-6, 253-7. PubMed ID: 11990789
[TBL] [Abstract][Full Text] [Related]
17. The müllerian inhibitor and mammalian sexual development.
Behringer RR
Philos Trans R Soc Lond B Biol Sci; 1995 Nov; 350(1333):285-8; discussion 289. PubMed ID: 8570693
[TBL] [Abstract][Full Text] [Related]
18. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor.
Gouédard L; Chen YG; Thevenet L; Racine C; Borie S; Lamarre I; Josso N; Massague J; di Clemente N
J Biol Chem; 2000 Sep; 275(36):27973-8. PubMed ID: 10854429
[TBL] [Abstract][Full Text] [Related]
19. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
Zhan Y; Fujino A; MacLaughlin DT; Manganaro TF; Szotek PP; Arango NA; Teixeira J; Donahoe PK
Development; 2006 Jun; 133(12):2359-69. PubMed ID: 16687449
[TBL] [Abstract][Full Text] [Related]
20. Effect of prenatal exposure to diethylstilbestrol on Müllerian duct development in fetal male mice.
Visser JA; McLuskey A; Verhoef-Post M; Kramer P; Grootegoed JA; Themmen AP
Endocrinology; 1998 Oct; 139(10):4244-51. PubMed ID: 9751506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
